1 T U F T S C S D D P R E S E N T S Leadership for Drug Development Teams J U LY 8-9, 2014 DoubleTree by Hilton Hotel Boston, MA A leadership development opportunity with demonstrated results Create motivated, accountable teams Achieve project goals and milestones Build collaboration across organizations
2 Leadership for Drug Development Teams Why you should take this course Tufts CSDD s Leadership for Drug Development Teams uses real cases from front-line R&D leaders to build practical skills for leading multidisciplinary teams to collaborate effectively. With class size limited to 35, and a hands-on, interactive format, this course draws consistent praise: I ve attended various training courses/workshops before. Some required pre-course preparation but none had a post-course follow-up like this one, to apply the tools and concepts in the real work setting. What I learned from this course has had a long-lasting impact on my daily actions. Hui Wang, MS, MBA, PMP Associate Director, Program Management, Regeneron Pharmaceuticals The concepts introduced in the leadership course have provided me with the tools necessary to tackle the dynamics within my drug discovery team, helping us improve our effectiveness as a group. I would strongly recommend this to all who seek to better their organizations. Matthew Cullen, PhD Scientist II, Proteostasis Therapeutics, Inc. Proven leadership tools sharpened by over 300 bio/pharma teams Now in its 13th year, this unique course draws upon the real experiences of front-line professionals across the spectrum of R&D from drug discovery and pre-clinical research to clinical development, regulatory affairs, CMC, and marketing. Our curriculum is continuously updated to address the rapidly changing challenges of life science R&D. A leadership development opportunity with demonstrated results Team dynamics diagnosing barriers to progress. Alignment moving from unilateral to mutual action. Cross-functionality managing clashing perspectives. Facilitation creating productive conversations. Knowledge creation expanding your team s ability to learn. Collaboration bridging organizational boundaries.
3 A G E N D A TUESDAY, JULY 8, 2014 Registration and Continental Breakfast begin at 7:30 a.m. Program begins at 8:30 a.m. Introduction Foundations of Cross-Functional Leadership Interactive presentation: Understand the conversational building blocks of effective cross-functional leadership. A New Leadership Model for Pharmaceutical Teams Case presentation and discussion: We try to treat drug development as a predictable, linear activity but reality is dynamic and complex. Learn what it takes to break old habits of thinking and build your team s ability to adapt. Create More Productive Conversations Skill practice using actual cross-functional vignettes: Recognize clashing perspectives and move difficult conversations forward. Lunch Group Decision-Making Interactive case workshop: Pull together all the stakeholders and generate informed commitment to tough R&D choices. Bridge Boundaries in Cross- Functional Teams Hands-on application of new tools to more complex challenges: Improve team performance by working through differences in culture, organizational structure, and conversational routines. WEDNESDAY, JULY 9, 2014 Continental Breakfast begins at 8:00 a.m. Program begins at 8:30 a.m. Put Leadership Skills into Action Practice using new tools in real-time settings: Lead productive conversations in cross-functional teams about critical issues of substance. Build the Team s Communicative Competence Case exercise: Sharpen your skills at seeing how teams get stuck, and expand your repertoire for improving the team s ability to perform when the stakes are highest. Lunch Improve Performance Case Teams Intensive casework in small teams: Practice more effective leadership for real team problems. Action Planning Map out ongoing skill development: Commit to building the leadership practices that will be most powerful for you. Course Adjourns at 5:00 p.m. To register or for more information, visit leadership_course The Current Environment of Pharmaceutical Innovation Presentation and Q&A: Understand the importance of leadership skill in meeting the industry s productivity challenge. Networking Reception concludes at 7:30 p.m.
4 ADDITIONAL INFORMATION Tuition Early-bird Registration (until May 1, 2014) $2,795 USD Registration $2,995 USD Tufts CSDD Sponsor Rate $2,675 USD Academic/Non-Profit/Government Rate $2,575 USD Discounts available for groups of three or more. Call Jonathan at or for more information. Registration Registration for the course will be taking place online at courses/leadership_course. Contact us by at or by phone at if you require any assistance. Course Location and Accommodations The course will be held at the DoubleTree by Hilton Hotel, 821 Washington Street, Boston, MA A block of rooms at the DoubleTree Hotel has been reserved for our Leadership course participants at a preferred rate of $189 a night. These rooms will be available at this rate until June 8, To book, contact the Double Tree Hotel at and be sure to mention the Tufts CSDD Leadership Course to obtain the preferred room rate. Cancellation Policy Full tuition will be refunded (minus a non-refundable $250 USD registration fee) for cancellations received before June 1, Fifty percent of the tuition (minus the $250 USD registration fee) will be refunded for cancellations received June 2 22, No refunds will be issued for cancellations received June 23, 2014 and after. Substitutions may be made through July 1, If the course is postponed due to events beyond the control of Tufts CSDD, tuition will be applied to the rescheduled event. Tufts CSDD reserves the right to alter the venue if necessary and is not responsible for any airfare, hotel, or other costs incurred by registrants if the course is canceled or postponed.
5 O U R P R E S E N T E R S Merle Kummer, MBA Merle Kummer is the founder and principal of Kummer Consulting LLC in Belmont, Massachusetts. Her work enables people in biopharma R&D to create together what they care about most and to believe that they can. A pioneer in the field of leading cross-disciplinary R&D, in 2002 she created the first course on leading pharmaceutical teams for the Tufts Center for the Study of Drug Development. In addition, she designs and manages learning programs for life science organizations. She coaches executives for leadership development and consults to R&D groups on innovation capability, team effectiveness, and decision-making, working with such clients as Biogen Idec, Celgene, Shire Human Genetics Therapies, and Genentech. Robert Putnam, EdD Bob Putnam is a founding partner of Action Design, a consulting firm specializing in organizational learning and professional development. He works with senior executives to develop effective leadership groups, facilitates conversations across organizational boundaries, and consults on organizational change. He also teaches in executive education and professional development programs. Bob is a co-developer of action science, an approach to inquiry that emphasizes knowledge for action. He is co-author of the book Action Science with Chris Argyris and Diana McLain Smith. Bob earned his doctorate in Counseling and Consulting Psychology from Harvard University. He holds a degree in Political Science from Syracuse University and was a Woodrow Wilson Fellow in Political Science. Kenneth I Kaitin, PhD Dr. Kaitin is Director of the Tufts Center for the Study of Drug Development and Professor at Tufts University School of Medicine. He is also a visiting lecturer at the Tuck School of Business at Dartmouth College, and serves on the faculty of the European Center for Pharmaceutical Medicine at the University of Basel. Dr. Kaitin is an internationally recognized expert on drug development science and policy. He writes and speaks regularly on pharmaceutical R&D issues, and has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, Dr. Kaitin is currently Editor-in-Chief of Expert Review of Clinical Pharmacology and serves as an expert consultant to the U.S. Department of Defense on bioterror countermeasure initiatives. Dr. Kaitin received his BS from Cornell University and a PhD in pharmacology from the University of Rochester.
6 Leadership for Drug Development Teams COACHING COMPANION PROGRAM Unlike any other course in the industry, Tufts CSDD offers a proven follow-up program that ensures leadership improvement on the job. This companion program won t take time away from work: rather, you will prepare for real meetings, presentations, and decisions in up to seven personalized learning sessions with lead instructor Merle Kummer. A $1,750 value, made available to Leadership Course participants for $975. Visit our website at for more details and how to sign up. About the Tufts Center for the Study of Drug Development The Tufts Center for the Study of Drug Development at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. Tufts CSDD conducts a wide range of in-depth analyses on pharmaceutical issues and hosts symposia, workshops, and public forums. To find out more about Leadership for Drug Development Teams and other programs conducted by Tufts CSDD, visit us at our website or contact us: Tufts Center for the Study of Drug Development 75 Kneeland Street, Suite 1100 Boston, MA